scholarly journals Lung cancer incidence and mortality trends in the Republic of Belarus (1990-2019)

2021 ◽  
Vol 62 (4) ◽  
pp. 9-15
Author(s):  
V. Kurchin ◽  
A. Kurchenkov ◽  
A. Evmenenko ◽  
L. Levin

favorable malignant diseases globally. In the Republic of Belarus, it ranks third (8.2%) in the cancer incidence structure and first (21.5%) in the cancer mortality structure. The object of the study were the lung cancer incidence and mortality trends in the Republic of Kazakhstan in 1990-2019. Methods: The present study included all patients - residents of Belarus, registered in the national cancer registry from 1990 to 2019 with a diagnosis of lung cancer (ICD-10 code: C33-C34). Demographic variables included gender, age, and area of residence (urban or rural). The number of PD cases is presented as absolute values and rough intensity indicators per 100,000 population. Standardized morbidity and mortality rates are calculated using the world standard (World) and are indicated per 100,000 population. Results: In the study period, the standardized incidence rate decreased from 27.5 to 25.6 per 100 000 population (– 7.1%, p<0.01). In males, it decreased from 62.1 to 54.6 per 100 000 males (– 12.1%, p<0.001); in females, it increased from 5.3 to 6.4 per 100 000 females (+20.7%, p<0.05). The standardized lung cancer mortality rate has decreased over the study period from 23.0 to 18.3 per 100 000 population (– 20.4%, p<0.001). In males, it went down from 53.6 to 40.7 (– 24.1%, p<0.001), and in women it changed slightly from 3.6 to 3.7 (+2.8%, p>0.05) per 100 000 of the relevant sex. The average annual increase in standardized mortality decreased eight times faster than the growth in standardized incidence. Conclusion: In the Republic of Belarus, lung cancer incidence is increasing in males and decreasing in females. At that, lung cancer mortality is decreasing. Quality specialized cancer care creates conditions for quicker negative growth of lung cancer standardized mortality vs. incidence

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Gisele Aparecida Fernandes ◽  
Fabrício dos Santos Menezes ◽  
Luiz Felipe Silva ◽  
José Leopoldo Ferreira Antunes ◽  
Tatiana Natasha Toporcov

Abstract The present study was conducted to evaluate the socioeconomic inequality related to lung cancer mortality rates and trends between 2000 and 2015 according to gender in Brazil. We retrieved the death records for cases of lung cancer (ICD-10 C33 C34) from 2000 to 2015 in adults age 30 years and older in Brazilian Regions from official databases (DATASUS) and corrected for ill-defined causes. The Prais-Winsten regression method and Pearson correlation were applied. The results were considered statistically significant when p < 0.05. The correlation between the lung cancer mortality rates and the HDI decreased when the rates for the first and last years of the historical series were compared in men (r = 0.77; r = 0.58) and women (r = 0.64; r = 0.41). However, the correlation between the trends in the lung cancer mortality rates and the HDI was negative in men (r = − 0.76) and women (r = − 0.58), indicating larger reductions (or smaller additions) among the Federative Units with the highest HDI, in contrast to trends reflecting a greater increase in those with the lowest HDI. Our results suggest a relevant inequality in the trends of mortality from lung cancer in Brazil.


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e13091-e13091
Author(s):  
Martin CS Wong ◽  
Stephen Lam Chan ◽  
Xiang Qian Lao ◽  
Lap Ah Tse ◽  
KF Ho ◽  
...  

e13091 Background: Lung cancer is the leading cause of cancer death worldwide. We examined the correlation between lung cancer incidence/mortality and country-specific socioeconomic development, and evaluated the most recent global patterns and trends of this cancer in 38 countries. Methods: We retrieved age-standardized incidence rates of lung cancer in 2012 from the GLOBOCAN database. Temporal patterns were assessed for all countries obtained from the Cancer Incidence in Five Continents volumes I-X and the WHO mortality database. Simple linear regression analysis was used to evaluate their correlations with Human Development Index (HDI) and Gross Domestic Product (GDP) per capita. The average annual percent change (AAPC) of the incidence and mortality trends in the most recent 10 years were evaluated from join-point regression analysis according to country and gender. The statistical significance of AAPC was ascertained comparing with zero, and all insignificant AAPCs were regarded as having “stable trends”. Results: The global incidence and mortality of lung cancer varied by 31-fold. Country-specific HDI was strongly correlated with age-standardized incidence (r = 0.70) and mortality (r = 0.67), and so was GDP per capita to a lesser extent (r = 0.24 to 0.55) (all p < 0.001). Among men, 22 and 30 (out of 38 and 36) countries showed declining incidence and mortality trends, respectively; whilst among women, 19 and 16 countries showed increasing incidence and mortality trends, respectively. The AAPCs ranged from -2.8 to -0.6 (incidence) and -3.6 to -1.1 (mortality) among countries with declining trend in men, whereas the AAPC range was 0.4 to 8.9 (incidence) and 1 to 4.4 (mortality) among countries with increasing trends in women. Among women, Brazil, Spain and Cyprus had the greatest incidence increase, and all countries in Western, Southern and Eastern Europe had increasing mortality. Conclusions: Countries with higher socioeconomic development had higher lung cancer incidence and mortality. The incidence and mortality rates of lung cancer were increasing in many countries among women but declining in most countries among men, highlighting the need for regular surveillance and global preventive measures.


Author(s):  
Gisele Aparecida Fernandes ◽  
Eduardo Algranti ◽  
Gleice Margarete de Souza Conceição ◽  
Victor Wünsch Filho ◽  
Tatiana Natasha Toporcov

There are scarce epidemiological studies on lung cancer mortality in areas exposed to asbestos in developing countries. We compared the rates and trends in mortality from lung cancer between 1980 and 2016 in a municipality that made extensive use of asbestos, Osasco, with rates from a referent municipality with lower asbestos exposure and with the rates for the State of São Paulo. We retrieved death records for cases of lung cancer (ICD-9 C162) (ICD-10 C33 C34) from 1980 to 2016 in adults aged 60 years and older. The join point regression and age-period-cohort models were fitted to the data. Among men, there was an increasing trend in lung cancer mortality in Osasco of 0.7% (CI: 0.1; 1.3) in contrast to a mean annual decrease for Sorocaba of -1.5% (CI: −2.4; −0.6) and a stable average trend for São Paulo of -0.1 (IC: −0.3; 0.1). Similar increasing trends were seen in women. The age-period-cohort model showed an increase in the risk of death from 1996 in Osasco and a reduction for Sorocaba and São Paulo State during the same period. Our results point to a need for a special monitoring regarding lung cancer incidence and mortality in areas with higher asbestos exposure.


2010 ◽  
Vol 18 (3) ◽  
pp. 71-74 ◽  
Author(s):  
Vladimir Petrovic ◽  
Marica Miladinov-Mikov ◽  
Tihomir Dugandzija

Background: Lung cancer is the leading cancer among men in cancer incidence as well as in cancer death. More recently, unpublished data showed that in women, lung cancer is in the second place in both incidence and mortality in Vojvodina. Methods: Data used for analyses were provided by Cancer Registry of Vojvodina, Oncology Institute of Vojvodina in Sremska Kamenica and from the Bureau of statistics. Descriptive epidemiological method was used. Data were analyzed topographically for two periods of observation, first from 1985 until 1995 and then from 1996 until 2005, separately for male and female population. Results: During the period from 1996-2005, age standardized incidence rate in male patients higher than 140/100,000 was registered in 14 municipalities with the highest incidence of 188.8/100,000. In 40 out of 44 municipalities of Vojvodina, an increase in lung cancer incidence in male patients was registered. Mortality higher than 140/100,000 was registered in 4 municipalities; the highest mortality was 209.9/100,000. In 41 out of 44 municipalities of Vojvodina, an increase in lung cancer mortality in male patients was registered. During the period from 1996-2005, age standardized incidence rate in female patients higher than 20/100,000 was registered in 29 municipalities with the highest incidence of 37.0/100,000. In 39 out of 44 municipalities of Vojvodina, an increase in lung cancer incidence in female patients was registered. Mortality in female patients higher than 20/100,000 was registered in 19 municipalities with the highest mortality of 27.2/100,000. In 33 out of 44 municipalities of Vojvodina, an increase in lung cancer mortality in female patients was registered. Conclusion: Vojvodina is a region with high lung cancer incidence and mortality rates. Incidence and mortality rates in male patients are higher according to topographical distribution than respective incidence in regions and municipalities in countries of the EU, while incidence and mortality rates in female patients are at the similar level as in the EU. In relation to results of the previous studies, we registered an important increase in lung cancer incidence and mortality rates in both male and female patients in the majority of municipalities of Vojvodina.


2021 ◽  
Vol 27 ◽  
Author(s):  
Gabriella Gálffy ◽  
Aladár Vastag ◽  
Krisztina Bogos ◽  
Zoltán Kiss ◽  
Gyula Ostoros ◽  
...  

Objective: Hungary has one of the highest incidences and mortality rates of lung cancer (LC), therefore the objective of this study was to analyse and compare LC incidence and mortality rates between the main Hungarian regions.Methods: This nationwide, retrospective study used data from the National Health Insurance Fund and included patients aged ≥20 years who were diagnosed with lung cancer (ICD-10 C34) between Jan 1, 2011 and Dec 31, 2016. Age-standardized incidence and mortality rates were calculated and compared for the main regions.Results: The highest incidence rate in males was recorded in Northern Hungary (146.8/100,000 person-years [PY]), while the lowest rate was found in Western Transdanubia (94.7/100,000 PY in 2011). All rates showed a declining trend between 2011 and 2016, with the largest decrease in the Northern Great Plain (−20.0%; p = 0.008). LC incidence and mortality rates in women both showed a rising tendency in all regions of Hungary, reaching the highest in Central Hungary (59.86/100,000 PY in 2016). Lung cancer incidence and mortality rates in males correlated with the level of education and smoking prevalence (p = 0.006 and p = 0.01, respectively) in the regions. A correlation with GDP per capita and Health Development Index (HDI) index could also be observed in the Hungarian regions, although these associations were not statistically significant. No correlations could be detected between these parameters among females.Conclusion: This analysis revealed considerable differences in the epidemiology of LC between the 7 main Hungarian regions. LC incidence and mortality rates significantly correlated with smoking and certain socioeconomic factors in men, but not in women. Further research is needed to explain the regional differences.


2005 ◽  
Vol 13 (1) ◽  
pp. 11-15 ◽  
Author(s):  
Vladimir Petrovic ◽  
Marica Miladinov-Mikov

BACKGROUND: Studies conducted in Vojvodina from 1960 to 1978 showed that the highest number and percentage of lung cancer cases and deaths occurred in seventh decade of life. Our aim was to analyze epidemiological characteristics of lung cancer in Vojvodina demographically from 1989 to 1998. METHODS: Data used for analyses were provided by the Cancer Registry of Vojvodina from the Institute of Oncology Sremska Kamenica. Descriptive epidemiological method was used. RESULTS: The sex ratio (males to females) of lung cancer incidence in Vojvodina is 5.14. Our study showed that the most unfavorable lung cancer incidence trends were present in age groups ranged from 45 to 49, 60 to 64, 65 to 69, and 70 to 74 years in men and in age groups ranged from 35 to 39, 40 to 44, and 45 to 49 years in women. We also found that the most unfavorable lung cancer mortality trends were present in age groups ranged from 45 to 49, 60 to 64, 65 to 69, and 70 to 74 years in men and in age groups range from 45 to 49 and 70 to 74 years in women. Favorable lung cancer mortality and incidence trend was present only in the age group ranged from 80 to 84 years in men. The highest percentage of diseased and deaths was in the age group ranged from 60 to 69 years for both sexes. In younger age groups the percentage of diseased was less than 2%. CONCLUSION: Preventive measures against lung cancer in our population do not show good results yet. This is either because of greater exposure of population to the risk factors or because of greater exposure to the risk factors of certain age cohorts. Decrease in sex ratio has shown that females are closing onto males when we talk about numbers of new lung cancer cases. It is clear that lung cancer incidence trends in males by age groups has shown greater variability while in females variability occurs on smaller scale when lung cancer incidence trends by age groups are discussed.


2008 ◽  
Vol 61 (1-2) ◽  
pp. 16-21 ◽  
Author(s):  
Natasa Maksimovic ◽  
Kyriakos Spanopoulos

Introduction. Lung cancer represents the most common malignant tumour among men, and appears more and more frequently among women in many countries worldwide. The aims of this descriptive epidemiological study were to evaluate the mortality trends of all malignant tumours and lung cancer in Central Serbia from 1990 to 1999, and to estimate the incidence, mortality and the basic demographic characteristics of lung cancer in Central Serbia in 1999. Material and methods. The source of data concerning cancer cases in 1999 was the Cancer Registry of Central Serbia, while data of the Republic Statistics Institute were used for the analysis of mortality trends for the period 1990-1999. All rates were standardized by the direct method, to the world standard population. Confidence intervals for mortality rates were assessed with 95% level of probability. Linear regression coefficient was determined by Fisher's test. Results. The mortality rates showed rising tendencies for both lung cancer (y=-1876.26+0.96x, p=0.028 for men; y=654.78U).33x, p-0.001 for women) and all malignant tumours (y=-4139.88+2.15x, p=0.163 for men; y=3649.68 + 1.88x, p=0.016 for women), with statistically significant increase being observed for all trends, except all malignant tumours among men. In the year 1999, lung cancer ranked first among men and third among women, with 29.2% and 10.3% of cancer mortality respectively. The age-specific mortality rates were much higher in men in all age groups. Mortality increased with age and the highest rates were found in the age group 70-74 for both sexes. The highest incidence and mortality rates were reported in Belgrade, Moravicki and Sumadijski district. .


2021 ◽  
Vol 60 (2) ◽  
pp. 36-38
Author(s):  
B. А. Abdurakhmanov ◽  
Z. К. Avizovа

Lung cancer is still leading in the structure of cancer incidence and mortality worldwide. Delay in appropriate treatment increases the probability of death from this disease. Purpose: to study foreign scientific publications of recent years on the mortality from lung cancer due to delayed treatment. Results: The analysis of global literature for 2010-2020 shows that any delay in lung cancer treatment after establishing the diagnosis reduces the survival rates. Recent studies provide a qualitative assessment of the effect of delay in treatment on cancer mortality for prioritization and modeling. The indications for surgery, systemic treatment, and radiation therapy in seven types of cancer, including lung cancer, evidence a significant association between delay in treatment and increased mortality. The researchers believe that early diagnostics increase the treatment efficacy. Conclusion: Analyzing the barriers to timely treatment for lung cancer can help clarify and assess the impact of delayed treatment on survival. Policies designed to minimize delays in treatment can improve survival outcomes.


Sign in / Sign up

Export Citation Format

Share Document